Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG CLASS:
PTK7-targeted antibody-drug conjugate
DRUG CLASS:
PTK7-targeted antibody-drug conjugate
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related drugs:
‹
BCG033 (3)
ABBV-647 (2)
BCG033 (3)
ABBV-647 (2)
›
Associations
(5)
News
Trials
Phase
Status
Apply
Phase
Status
Apply
An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer (NCT04189614)
Phase 1b
AbbVie
AbbVie
Active, not recruiting
Phase 1b
AbbVie
Active, not recruiting
Last update posted :
06/27/2023
Initiation :
02/13/2020
Primary completion :
02/13/2024
Completion :
02/13/2024
PTK7
|
PTK7 expression
|
cofetuzumab pelidotin (ABBV-647)
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login